SPX Technologies shares were down roughly 3% in Monday trading, extending weakness seen earlier in March after the market focused on an impairment-related headline tied to the company’s 2026 outlook discussion and accounting items. Over the last few weeks, investor attention has been sensitive to any signals of margin pressure, integration costs, or non-cash charges, particularly for higher-multiple industrial names.

The most recent company-specific issue weighing on the stock is the impairment charge that was highlighted in March and contributed to a sharp selloff at the time. Even though impairments are typically non-cash, they often trigger questions about forecasting, asset quality, and whether the business line involved is underperforming or being repositioned—concerns that can keep pressure on the stock for multiple sessions after the initial drop. (simplywall.st)

Early on March 30, there were no widely-circulated new SPX Technologies press releases or SEC headlines explaining a fresh single-day decline, which points to a continuation move rather than a new shock. In that setup, the selloff can reflect lingering positioning changes after the impairment news, plus broader risk-off conditions—rising yields and tighter financial-conditions concerns have been a dominant driver of equity volatility into late March. (ig.com)

Investors will look for any follow-through disclosure in SEC filings or management commentary that clarifies what drove the impairment and whether it has implications for 2026 segment profitability, return on invested capital, or acquisition strategy. Traders will also watch whether additional analyst notes tie the impairment to changes in estimates, and whether SPXC stabilizes as macro volatility eases. (spx.com)